HLA-A and melanoma: Malme-3M, a RAB7B+ (Supplemental Figure 3E) melanoma cell line, was engineered to express HLA-A*11:01+ (Malme-3MA*11:01, Supplemental Figure 3D) and tested as a target for endogenous RAB7B12–21 presentation.